Targeting metalloenzymes for therapeutic intervention

AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …

Chemical strategies to target bacterial virulence

M Garland, S Loscher, M Bogyo - Chemical reviews, 2017 - ACS Publications
Antibiotic resistance is a significant emerging health threat. Exacerbating this problem is the
overprescription of antibiotics as well as a lack of development of new antibacterial agents …

[图书][B] Privileged structures in drug discovery: medicinal chemistry and synthesis

L Yet - 2018 - books.google.com
A comprehensive guide to privileged structures and their application in the discovery of new
drugs The use of privileged structures is a viable strategy in the discovery of new medicines …

Nascent pharmacological advancement in adamantane derivatives

A Ragshaniya, V Kumar, RK Tittal… - Archiv der Pharmazie, 2024 - Wiley Online Library
The adamantane moiety has attracted significant attention since its discovery in 1933 due to
its remarkable structural, chemical, and medicinal properties. This molecule has a notable …

An integrated pharmacophore/docking/3D-QSAR approach to screening a large library of products in search of future botulinum neurotoxin A inhibitors

D Gentile, G Floresta, V Patamia… - International journal of …, 2020 - mdpi.com
Botulinum toxins are neurotoxins produced by Clostridium botulinum. This toxin can be
lethal for humans as a cause of botulism; however, in small doses, the same toxin is used to …

Methods for hydroxamic acid synthesis

MA Alam - Current organic chemistry, 2019 - ingentaconnect.com
Substituted hydroxamic acid is one of the most extensively studied pharmacophores
because of their ability to chelate biologically important metal ions to modulate various …

Challenges in searching for therapeutics against Botulinum Neurotoxins

M Pirazzini, O Rossetto - Expert opinion on drug discovery, 2017 - Taylor & Francis
ABSTRACT Introduction: Botulinum neurotoxins (BoNTs) are the most potent toxins known.
BoNTs are responsible for botulism, a deadly neuroparalytic syndrome caused by the …

Strategies to counteract botulinum neurotoxin A: nature's deadliest biomolecule

L Lin, ME Olson, LM Eubanks… - Accounts of chemical …, 2019 - ACS Publications
Conspectus Botulinum neurotoxin serotype A (BoNT/A), marketed commercially as Botox, is
the most toxic substance known to man with an estimated intravenous lethal dose (LD50) of …

Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain

H Seki, S Pellett, P Šilhár, GN Stowe, B Blanco… - Bioorganic & Medicinal …, 2014 - Elsevier
Abstract Botulinum neurotoxin A (BoNT/A) is the most potent toxin known. Unfortunately, it is
also a potential bioweapon in terrorism, which is without an approved therapeutic treatment …

Catch and anchor approach to combat both toxicity and longevity of botulinum toxin A

L Lin, ME Olson, T Sugane, LD Turner… - Journal of medicinal …, 2020 - ACS Publications
Botulinum neurotoxins have remarkable persistence (∼ weeks to months in cells), outlasting
the small-molecule inhibitors designed to target them. To address this disconnect, inhibitors …